SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SARS and Avian Flu
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (2722)10/15/2005 3:50:21 PM
From: Elroy Jetson  Read Replies (1) of 4232
 
I must apologize. I think some of my responses, to your suggestion of passive immune therapy (injections of IGG from people previously infected with H5N1), were colored by my previous years of experience dealing with the chronic misrepresentations from the quacks who run Hemacare.

I have heard enough false claims for the benefits of passive immune therapy to last several lifetimes. I'm glad we never gave them a penny.

But I do believe that IGG injections would be:

less safe than antiviral drugs with little reason to expect better protection;

rendered ineffective by viral mutation in the same way as antiviral drugs;

more expensive than antiviral drugs;

certainly less available than antiviral drugs by perhaps a factor of one hundred million.

If a pandemic develops, I'm sure IGG injections will be trialled for health-care workers.
.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News